UBE2T and hepatocellular carcinoma: In addition, we observed that the subcutaneous xenografts derived from HCC-LM3 and MHCC-97H cells with UBE2T overexpression displayed quicker tumor growth and heavier tumor weight compared with those derived from control cells (Fig. 1E–G and Suppl.